Gloria Vega

Dr. Gloria Vega

Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9052, USA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2009 in Hepatology
Verified
Journal Article
Open access
PDF file
RGRichard Guerrero
Richard Guerrero
Gloria VegaGloria Vega
Gloria Vega
SGScott M. Grundy
Scott M. Grundy
JBJeffrey D. Browning
Jeffrey D. Browning
Nonalcoholic fatty liver disease is a burgeoning problem. We have previously shown that Hispanics were at greater risk for nonalcoholic fatty liver disease than were African‐Americans despite a similar prevalence of risk factors between these groups. We have performed the largest, population‐based study to date (n = 2170) utilizing proton magnetic resonance (MR) spectroscopy, dual‐energy x‐ray absorptiometry, and multislice abdominal MR imaging to determine the contribution of body fat distribution to the differing prevalence of hepatic steatosis in the three major U.S. ethnic groups (African‐American, Hispanic, Caucasian). Despite controlling for age and total adiposity, African‐Americans had less intraperitoneal (IP) fat and more lower extremity fat than their Hispanic and Caucasian counterparts. The differences in hepatic triglyceride content (HTGC) between these groups remained after controlling for total, abdominal subcutaneous, and lower extremity adiposity; however, controlling for IP fat nearly abolished the differences in HTGC, indicating a close association between IP and liver fat regardless of ethnicity. Despite the lower levels of IP and liver fat in African‐Americans, their prevalence of insulin resistance was similar to Hispanics, who had the highest levels of IP and liver fat. Furthermore, insulin levels and homeostasis model assessment values were highest and serum triglyceride levels were lowest among African‐Americans after controlling for IP fat. Conclusion: IP fat is linked to HTGC, irrespective of ethnicity. The differing prevalence of hepatic steatosis between these groups was associated with similar differences in visceral adiposity. The metabolic response to obesity and insulin resistance differs in African‐Americans when compared to either Hispanics or Caucasians: African‐Americans appear to be more resistant to both the accretion of triglyceride in the abdominal visceral compartment (adipose tissue and liver) and hypertriglyceridemia associated with insulin resistance. (HEPATOLOGY 2009.)

1 April 2003 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
Gloria VegaGloria Vega
Gloria Vega
MWMyron F. Weiner
Myron F. Weiner
ALAnne M. Lipton
Anne M. Lipton
KBKlaus von Bergmann
Klaus von Bergmann
DLDieter Lütjohann
Dieter Lütjohann
DSDoris Svetlik
Doris Svetlik
ALZHEIMER DISEASE (AD) is the most common late-life dementing illness.1 A central event in the development of AD is thought to be abnormal processing of the cell membrane–associated amyloid precursor protein followed by deposition of toxic β-amyloid protein in the form of amyloid plaques in the extracellular space of the neocortex.2 It has been demonstrated that amyloid plaques contain apolipoprotein E (apo E), a lipid transporter. It has also been shown that there is a higher frequency of the apo E allele named ϵ4 in patients with AD than in the general population (allele frequency of 40% vs 15%).3 However, the mechanism of this association is still poorly understood at the molecular level. Another emerging lipid candidate for AD risk is the level of 24S-hydroxycholesterol in plasma.4

1 April 2003 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Gloria VegaGloria Vega
Gloria Vega
PMPatrick T.S Ma
Patrick T.S Ma
NCNilo B Cater
Nilo B Cater
NFNeil Filipchuk
Neil Filipchuk
SMShinichi Meguro
Shinichi Meguro
SGScott M Grundy
Scott M Grundy

18 July 2016 in Nutrition & Diabetes
Verified
Journal Article
Open access
PDF file
INIan Neeland
Ian Neeland
SGS M Grundy
S M Grundy
XLX Li
X Li
BAB Adams-Huet
B Adams-Huet
Gloria VegaGloria Vega
Gloria Vega
Background/Objectives: Visceral adipose tissue (VAT) mass, a risk factor for cardiometabolic complications of obesity, is usually measured by magnetic resonance imaging (MRI) but this method is not practical in a clinical setting. In contrast, measurement of VAT by dual-x-ray absorptiometry (DXA) appears to circumvent the limitations of MRI. In this study, we compared measurements of VAT mass by MRI and DXA in the large, multiethnic cohort of the Dallas Heart Study (DHS). Subjects/Methods: About 2689 DHS participants underwent paired measurement of VAT by MRI and DXA. Sex-stratified analyses were performed to evaluate the correlation and agreement between DXA and MRI. Model validation was performed using bootstrapping and inter-reader variability was assessed. Results: Mean age of the cohort was 44 years, with 55% female, 48% Black and 75% overweight/obese participants. Regression analysis showed a linear relationship between DXA and MRI with R2=0.82 (95% confidence interval (CI) 0.81–0.84) for females and R2=0.86 (95% CI 0.85–0.88) for males. Mean difference between methods was 0.01 kg for females and 0.09 kg for males. Bland–Altman analysis showed that DXA tended to modestly underestimate VAT compared with MRI at lower VAT levels and overestimate it compared with MRI at higher VAT levels. Results were consistent in analyses stratified by race, body mass index status, waist girth and body fat. Inter-individual reader correlation among 50 randomly selected scans was excellent (inter-class correlation coefficient=0.997). Conclusions: VAT mass quantification by DXA was both accurate and valid among a large, multiethnic cohort within a wide range of body fatness. Further studies including repeat assessments over time will help determine its long-term applicability.

6 March 2013 in Journal of Obesity
Verified
Journal Article
Open access
PDF file
Gloria VegaGloria Vega
Gloria Vega
SGScott M. Grundy
Scott M. Grundy
Background. High adiponectin/leptin ratio may be protective from metabolic risks imparted by high triglyceride, low HDL, and insulin resistance.Methods. This cross-sectional study examines plasma adipokine levels in 428 adult men who were subgrouped according to low (<6.5 μg/mL)and high (≥6.5 μg/mL)adiponectin levels or a low or high ratio of adiponectin/leptin.Results. Men with high adiponectin/leptin ratio had lower plasma triglyceride and higher HDL cholesterol than those with low ratio. Similarly, those with high adiponectin/leptin ratio had lower TG/HDL cholesterol ratio and HOMA2-IR than those with low ratio. In contrast, levels of adiponectin or the ratio of adiponectin/leptin did not associate with systolic blood pressure. But the ratio of adiponectin/leptin decreased progressively with the increase in the number of risk factors for metabolic syndrome.Conclusion. Adipokine levels may reflect adipose tissue triglyceride storage capacity and insulin sensitivity. Leptin is an index of fat mass, and adiponectin is a biomarker of triglyceride metabolism and insulin sensitivity. Men with high adiponectin/leptin ratios have better triglyceride profile and insulin sensitivity than men with a low ratio regardless of waist girth.

8 July 2021 in Toxicology
Verified
Journal Article
Open access
MAMelvin E. Andersen
Melvin E. Andersen
BHBruno Hagenbuch
Bruno Hagenbuch
Udayan ApteUdayan Apte
Udayan Apte
JCJ. Christopher Corton
J. Christopher Corton
TFTony Fletcher
Tony Fletcher
MLMatthew Longnecker
Matthew Longnecker
Serum concentrations of cholesterol are positively correlated with exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) in humans. The associated change in cholesterol is small across a broad range of exposure to PFOA and PFOS. Animal studies generally have not indicated a mechanism that would account for the association in humans. The extent to which the relationship is causal is an open question. Nonetheless, the association is of particular importance because increased serum cholesterol has been considered as an endpoint to derive a point of departure in at least one recent risk assessment. To gain insight into potential mechanisms for the association, both causal and non-causal, an expert workshop was held Oct 31 and Nov 1, 2019 to discuss relevant data and propose new studies. In this report, we summarize the relevant background data, the discussion among the attendees, and their recommendations for further research.